Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to investigate the efficacy and tolerance of Ambroxol lozenges 20 mg
in the treatment of sore throat in patients with acute viral pharyngitis.